2022. Bimekizumab speed of response in patients with moderate to severe plaque psoriasis: Results from four phase 3/3b trials (BE VIVID, BE READY, BE SURE, and BE RADIANT). SKIN The Journal of Cutaneous Medicine. 6, 6 (Nov. 2022), s69. DOI:https://doi.org/10.25251/skin.6.supp.69.